Sandrine Heurtebise-Chrétien

5PUBLICATIONS
45CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursBiologically active moleculesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 18, 2024
Ablation of FAS confers allogeneic CD3- CAR T cells with resistance to rejection by T cells and natural killer cells.

Silvia Menegatti, Sheila Lopez-Cobo, Aurelien Sutra Del Galy

|Oct 27, 2023
Selective control of transposable element expression during T cell exhaustion and anti-PD-1 treatment.

Pierre-Emmanuel Bonté, Christina Metoikidou, Sandrine Heurtebise-Chretien

|Feb 03, 2023
Epigenetically controlled tumor antigens derived from splice junctions between exons and transposable elements.

Marianne Burbage, Ares Rocañín-Arjó, Blandine Baudon

Pageof 1